December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

5.765 -0.045 (-0.77%)
Delayed Quote Updated: 10:53 AM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cytek Biosciences, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
Industry’s First End-to-End Flow Cytometry Platform Covering Panel Design Through Data Analysis 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
Complementary Technologies Deliver an Integrated, End-to-End Clinical Flow Cytometry Workflow for Laboratories Across Europe 
From Cytek Biosciences, Inc.; Sysmex Europe SE
Via GlobeNewswire
News headline image
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
New 7-Laser Cytek Borealis™ System With Deep Ultraviolet and Infrared cFluor® Reagents; Cytek Aurora™ Evo System Enhancements for Automation and Workflow Efficiency 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
Issued on behalf of VentriPoint Diagnostics Ltd. 
From USA News Group
Via GlobeNewswire
News headline image
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
Anniversary Milestone Highlights Expanded Manufacturing Capacity, Stronger Asia-Pacific Presence, and Measurable Contributions to Global Supply Chain Resilience 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
Supports ISAC in Mission to Extend Flow Cytometry Reach Worldwide; Unveils Programs Offering Instrument Award and Research Grants 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
Spectral Flow Cytometry Pioneer Unveils Innovations Accelerating Efficiency and Discovery 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
Improved Sample Throughput, Automation Capabilities and Updated Hardware Design 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Reports First Quarter 2025 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
Company to Conduct Demonstrations, Educational Workshops and Tutorials at Key Industry Events 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
Increasing Accessibility for Flow Cytometry Applications in Emerging and Established Markets 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
World’s First Enhanced Small Particle (ESP™) Detection Sorter Enables Effective Content Isolation; Opens Door to Scientific Discoveries 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
Industry Leaders to Explore Cytek’s Advanced Cell Analysis Solutions at ICCS and ESCCA 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
Certification Emphasizes Unwavering Commitment to Quality and Is an Essential Step for U.S. Clinical Market Entry 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
Expanding Capabilities and Streamlining Experimental Workflows 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Announces $50 Million Stock Repurchase Program
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
New Enhanced Small Particle (ESP™) Detection Option for Cytek Northern Lights™ and Cytek Aurora™ Systems Expands Capabilities of Small Particle Research 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences Reports First Quarter 2024 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
Company to Conduct Educational Workshops and Tutorials at CYTO and AAI’s IMMUNOLOGY2024 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
From Cytek Biosciences, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.